GTCM
IRON icon

Gyon Technologies Capital Management’s Disc Medicine IRON Stock Holding History

Gyon Technologies Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-340
Closed -$14K – 514
2022
Q1 		$14K Buy
+340
New +$17.8K 0.01% 261

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Gyon Technologies Capital Management's IRON Position: Q2 2022 in Review

Gyon Technologies Capital Management sold out of Disc Medicine (IRON) in Q2 2022, closing a stake of 340 shares — an estimated $14K sold.

Gyon Technologies Capital Management first reported a position in IRON in Q1 2022 and held it in 1 quarter. The position peaked at $14K in Q1 2022. 50 funds tracked by Wall St. Rank hold IRON as of Q2 2022.

  • Gyon Technologies Capital Management reported no remaining Disc Medicine position as of Q2 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 340 Disc Medicine shares in Q2 2022, an estimated $14K.
  • Gyon Technologies Capital Management first reported a position in Disc Medicine in Q1 2022 and held it in 1 quarter.
  • Gyon Technologies Capital Management's Disc Medicine position peaked at $14K in Q1 2022.
  • 50 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.